Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 19
210
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

A new abietane diterpenoid glycoside from ajuga ovalifolia var. calantha

, , , , , , , , & show all
Pages 2856-2859 | Received 10 May 2018, Accepted 10 Jul 2018, Published online: 13 Nov 2018
 

Abstract

A new abietane diterpenoid glycoside, ajugaside B (1), along with three known compounds (2–4), were isolated from the whole plants of Ajuga ovalifolia var. calantha. The structure of the new compound (1) was elucidated by means of spectroscopic analyses (HRESIMS, IR, NMR and ECD). All of the isolated compounds were evaluated for their antitumor activities against MGC803, MCF-7, A549, HT29 and HepG2 cell lines. Compounds 3–4 showed moderate cytotoxicity against all tested cell lines with IC50 values of 1.8–7.3 μM.

Graphical Abstract

Acknowledgement

We gratefully acknowledge Prof. Cheng Yang of Si Chuan University for measuring CD and the support from Hong yuan County Productivity Promotion Center for collecting plant.

Disclosure statement

No conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China [grant number 81703693, 81774202]; The Youth Science and Technology Innovative Research Team Fund Project of Sichuan [grant number 2016TD0006]; Department of Science and Technology of Sichuan Province [grant number 2016SZYZF0002]; Department of Science and Technology of Chengdu [grant number 2016-HM01-00457-SF]; Education Department of Sichuan Province (grant number 18ZA0181).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.